Pulse Biosciences
PLSE
50 hedge funds and large institutions have $43.2M invested in Pulse Biosciences in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
53% more capital invested
Capital invested by funds: $28.3M → $43.2M (+$14.9M)
16% more funds holding
Funds holding: 43 → 50 (+7)
0.6% more ownership
Funds ownership: 10.6% → 11.2% (+0.6%)
69% less call options, than puts
Call options by funds: $814K | Put options by funds: $2.64M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.97M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$577K |
| 3 |
Morgan Stanley
New York
|
+$313K |
| 4 |
Millennium Management
New York
|
+$290K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$281K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
-$1.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$818K |
| 3 |
Goldman Sachs
New York
|
-$386K |
| 4 |
Barclays
London,
United Kingdom
|
-$142K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$95K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Goldman Sachs
New York
| – | -$386K | -20,761 | Closed |
|
|
NFA
52
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$95K | -5,126 | Closed |
|
|
PG
53
PEAK6 Group
Chicago,
Illinois
| – | -$85K | -4,582 | Closed |
|
54
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$2K | -124 | Closed |
|
|
SSB
55
Sandy Spring Bank
Olney,
Maryland
| – | +$354 | +15 | New |
|
PLSE Hedge Fund Activity: Q4 2017 in Review
50 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2017, worth a combined $43.2M — up 53% from $28.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PLSE positions and 5 closed out — a net gain of 7 holders — while 17 added to existing stakes and 10 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $7.97M. The largest seller was Harvest Capital Strategies, exiting entirely with an estimated $1.4M sold.
- 50 institutional investors held Pulse Biosciences (PLSE) as of Q4 2017, up from 43 in Q3 2017.
- Funds reported $43.2M of Pulse Biosciences stock for Q4 2017, up 53% quarter-over-quarter.
- 12 funds opened new Pulse Biosciences positions in Q4 2017 and 5 closed out, a net change of +7 holders.
- The largest Pulse Biosciences buyer in Q4 2017 was Citadel Advisors, an estimated $7.97M added.
- The largest Pulse Biosciences seller in Q4 2017 was Harvest Capital Strategies, an estimated $1.4M sold.
Based on aggregated 13F filings for Q4 2017.